Drudge Retort: The Other Side of the News

Drudge Retort

User Info

AMERICANUNITY

Subscribe to AMERICANUNITY's blog Subscribe

Menu

Special Features

Saturday, February 21, 2026

New GDP figures reflect subdued growth in 2025 from new trade policies and a weeks-long government shutdown. read more


Thursday, February 19, 2026

The gap between the value of goods imported into the US and American products sold to other countries widened by 2.1% compared to 2024 despite Trump's tariffs, hitting roughly $1.2 trillion (890m), official figures show. read more


Tuesday, February 17, 2026

Kristi Noem's new billionaire-class luxury jet that only seats 19, complete with two queen bedrooms, three bathrooms with high end showers and heated bidets, and a wet bar with a wine chiller, will be purchased on your dime from the slush fund Congress approved in the One Big Beautiful Bill. She claims it's for "High profile deportations." read more


Monday, February 16, 2026

Jonathan Cohn: A shocking move by RFK Jr.'s team has the industry spooked -- for good reason. read more


Thursday, February 12, 2026

A cascade of CBS News journalists have quit or reportedly taken buyouts ... read more


Comments

This is what having a heroin addict kook in charge of public health looks like.

This is not the type of development you would normally expect a pharmaceutical company to broadcast. But that's because there's nothing normal about the way the federal government is behaving in this saga"or, for that matter, how the government has been behaving ever since President Donald Trump put anti-vaccination crusader Robert F. Kennedy Jr. in charge of America's public health.

Moderna's flu shot, which uses mRNA technology made famous during the COVID-19 pandemic, is the product of a lengthy research and development process that goes back years. Along the way, Moderna scientists consulted directly with officials at the Food and Drug Administration, the agency inside of Kennedy's department (Health and Human Services) that is responsible for reviewing and approving vaccines.

Such consultation is normal. And a major focus of the discussion between the company and the regulators was how Moderna should test the new shot to demonstrate its safety and effectiveness. There was some back and forth"again, pretty routine"but ultimately the FDA agreed that Moderna's design for a trial was "acceptable," according to communication Moderna cited in its press release.

Moderna proceeded with the testing, got promising results and submitted its application. It had good reason to believe it would receive consideration and, in due time, outright approval. Instead, on February 3, Moderna got what's known as a "refuse to file" letter from the FDA, in which the agency said the company had not put the new vaccine to a sufficiently demanding test.

Drudge Retort
 

Home | Breaking News | Comments | User Blogs | Stats | Back Page | RSS Feed | RSS Spec | DMCA Compliance | Privacy